Astroglial Cells: Emerging Therapeutic Targets in the Management of Traumatic Brain Injury

6Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Traumatic Brain Injury (TBI) represents a significant health concern, necessitating advanced therapeutic interventions. This detailed review explores the critical roles of astrocytes, key cellular constituents of the central nervous system (CNS), in both the pathophysiology and possible rehabilitation of TBI. Following injury, astrocytes exhibit reactive transformations, differentiating into pro-inflammatory (A1) and neuroprotective (A2) phenotypes. This paper elucidates the interactions of astrocytes with neurons, their role in neuroinflammation, and the potential for their therapeutic exploitation. Emphasized strategies encompass the utilization of endocannabinoid and calcium signaling pathways, hormone-based treatments like 17β-estradiol, biological therapies employing anti-HBGB1 monoclonal antibodies, gene therapy targeting Connexin 43, and the innovative technique of astrocyte transplantation as a means to repair damaged neural tissues.

Cite

CITATION STYLE

APA

Czyżewski, W., Mazurek, M., Sakwa, L., Szymoniuk, M., Pham, J., Pasierb, B., … Rola, R. (2024, January 1). Astroglial Cells: Emerging Therapeutic Targets in the Management of Traumatic Brain Injury. Cells. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cells13020148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free